Abiomed Inc.
ABMD
Market Cap$17.18B
Close$
$383.91
0.8% upside
Current Fair Value
0.8% upsideUndervalued by 0.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $17.18 Billion |
|---|---|
| Enterprise Value | $16.36 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $3 |
| Beta | 0 |
| Outstanding Shares | 45,372,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 126.85 |
|---|---|
| PEG | 146.9 |
| Price to Sales | 16.57 |
| Price to Book Ratio | 11.55 |
| Enterprise Value to Revenue | 15.23 |
| Enterprise Value to EBIT | 64.38 |
| Enterprise Value to Net Income | 61 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Abiomed Inc.
1,371 employees
CEO: Michael Minogue Abiomed is a publicly-traded medical devices company that develops and manufactures the circulatory support device Impella, the world’s smallest heart pump. The company is headquartered in Danvers, Massachusetts and has three additional ...